Brian Lian - 03 Jan 2024 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
President & CEO, Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
03 Jan 2024
Net transactions value
-$4,469,612
Form type
4
Filing time
04 Jan 2024, 21:37:33 UTC
Previous filing
01 May 2023
Next filing
08 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Award $0 +150,000 +6.8% $0.000000 2,359,074 03 Jan 2024 Direct F1, F2
transaction VKTX Common Stock, par value $0.00001 per share Tax liability $1,888,335 -108,525 -4.6% $17.40 2,250,549 03 Jan 2024 Direct F3
transaction VKTX Common Stock, par value $0.00001 per share Award $0 +160,000 +7.1% $0.000000 2,410,549 03 Jan 2024 Direct F4
transaction VKTX Common Stock, par value $0.00001 per share Tax liability $1,846,401 -106,115 -4.4% $17.40 2,304,434 03 Jan 2024 Direct F5
transaction VKTX Common Stock, par value $0.00001 per share Tax liability $734,876 -39,552 -1.7% $18.58 2,264,882 04 Jan 2024 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Award $0 +360,000 $0.000000 360,000 03 Jan 2024 Common Stock 360,000 $17.40 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2022, 33.33% of which vested on January 3, 2024 upon the achievement of a non-financial performance goal.
F2 Includes 6,421 shares acquired on May 19, 2023 and 4,690 shares acquired on November 20, 2023 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
F3 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock units.
F4 Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.
F5 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units.
F6 25% of the shares subject to the option will vest on each anniversary of the grant date.